Literature DB >> 10924028

Decisions about access to health care and accountability for reasonableness.

N Daniels1.   

Abstract

Insurers make decisions that directly limit access to care (e.g., when deciding about coverage for new technologies or formulary design) and that indirectly limit access (e.g., by adopting incentives to induce physicians to provide fewer or different services). These decisions raise questions about legitimacy and fairness. By holding health plans accountable for the reasonableness of their decisions, it is possible to address these questions. Accountability for reasonableness involves providing publicly accessible rationales for decisions and limiting rationales to those that all "fair-minded" persons can agree are relevant to meeting patient needs fairly under resource constraints. This form of accountability is illustrated by examining its implications for the three examples of direct and indirect limit setting noted here.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  1999        PMID: 10924028      PMCID: PMC3455985          DOI: 10.1007/BF02344674

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  14 in total

1.  Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers.

Authors:  Norman Daniels; James Sabin
Journal:  Philos Public Aff       Date:  1997

2.  Paying physicians more to do less: financial incentives to limit care.

Authors:  David Orentlicher
Journal:  Univ Richmond Law Rev       Date:  1996-01

Review 3.  The impact of financial incentives on physician behavior in managed care plans: a review of the evidence.

Authors:  F J Hellinger
Journal:  Med Care Res Rev       Date:  1996-09       Impact factor: 3.929

Review 4.  Medical care costs: how much welfare loss?

Authors:  J P Newhouse
Journal:  J Econ Perspect       Date:  1992

5.  Quality of health care. Part 5: Payment by capitation and the quality of care.

Authors:  D M Berwick
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

6.  Making insurance coverage for new technologies reasonable and accountable.

Authors:  J E Sabin; N Daniels
Journal:  JAMA       Date:  1998-03-04       Impact factor: 56.272

7.  Closure, fair procedures, and setting limits within managed care organizations.

Authors:  N Daniels; J Sabin
Journal:  J Am Geriatr Soc       Date:  1998-03       Impact factor: 5.562

8.  Justice, fair procedures, and the goals of medicine.

Authors:  N Daniels
Journal:  Hastings Cent Rep       Date:  1996 Nov-Dec       Impact factor: 2.683

9.  Why saying no to patients in the United States is so hard. Cost containment, justice, and provider autonomy.

Authors:  N Daniels
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

10.  A national survey of the arrangements managed-care plans make with physicians.

Authors:  M R Gold; R Hurley; T Lake; T Ensor; R Berenson
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

View more
  17 in total

1.  Rules for medical markets: the impact of medicare contractors on coverage policies.

Authors:  Susan Bartlett Foote; Douglas Wholey; Rachel Halpern
Journal:  Health Serv Res       Date:  2006-06       Impact factor: 3.402

2.  Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients.

Authors:  Mireille M Goetghebeur; Monika Wagner; Hanane Khoury; Donna Rindress; Jean-Pierre Grégoire; Cheri Deal
Journal:  Cost Eff Resour Alloc       Date:  2010-04-08

3.  Principles versus procedures in making health care coverage decisions: addressing inevitable conflicts.

Authors:  Lindsay M Sabik; Reidar K Lie
Journal:  Theor Med Bioeth       Date:  2008-06-06

4.  From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking.

Authors:  Lalla Aïda Guindo; Monika Wagner; Rob Baltussen; Donna Rindress; Janine van Til; Paul Kind; Mireille M Goetghebeur
Journal:  Cost Eff Resour Alloc       Date:  2012-07-18

5.  Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.

Authors:  Michèle Tony; Monika Wagner; Hanane Khoury; Donna Rindress; Tina Papastavros; Paul Oh; Mireille M Goetghebeur
Journal:  BMC Health Serv Res       Date:  2011-11-30       Impact factor: 2.655

6.  Aligning values and outcomes in priority-setting for health.

Authors:  Gabriel Seidman; Rifat Atun
Journal:  J Glob Health       Date:  2016-12       Impact factor: 4.413

Review 7.  Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.

Authors:  Aris Angelis; Ansgar Lange; Panos Kanavos
Journal:  Eur J Health Econ       Date:  2017-03-16

8.  Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA.

Authors:  Monika Wagner; Hanane Khoury; Liga Bennetts; Patrizia Berto; Jenifer Ehreth; Xavier Badia; Mireille Goetghebeur
Journal:  BMC Cancer       Date:  2017-04-17       Impact factor: 4.430

Review 9.  Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.

Authors:  Mireille M Goetghebeur; Monika Wagner; Hanane Khoury; Randy J Levitt; Lonny J Erickson; Donna Rindress
Journal:  BMC Health Serv Res       Date:  2008-12-22       Impact factor: 2.655

10.  Can the EVIDEM Framework Tackle Issues Raised by Evaluating Treatments for Rare Diseases: Analysis of Issues and Policies, and Context-Specific Adaptation.

Authors:  Monika Wagner; Hanane Khoury; Jacob Willet; Donna Rindress; Mireille Goetghebeur
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.